• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Point Biopharma Global Inc (NQ: PNT )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Dec 26, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Point Biopharma Global Inc

    < Previous 1 2 3 4 Next >
    PNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of POINT Biopharma Global, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    5 Value Stocks To Watch In The Healthcare Sector
    Via Benzinga
    Amicus Therapeutics Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark
    One key metric to look for in a stock is an 80-plus RS Rating. Amicus Therapeutics stock hit that mark, with a jump from 74 to 82 Friday. 
    Via Investor's Business Daily
    Why Shares of Point Biopharma Global Rose Monday
    The company made a deal to help speed its clinical trials along. 
    Via The Motley Fool
    Earnings Preview: POINT Biopharma Global
    Via Benzinga
    Arlo Technologies, Array Technologies, AirSculpt Technologies And Other Big Stocks Moving Higher On Friday
    U.S. stocks traded slightly lower, with the Dow Jones dropping around 15 points on Friday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    7 Biotech Stocks With Huge Return Potential for Long-Term Investors
    Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers. 
    Via InvestorPlace
    Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
    From Lantheus Holdings, Inc.; POINT Biopharma Global Inc.
    Via GlobeNewswire
    7 Thrilling Biotech Stocks for Aggressive Investors to Buy
    Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
    Via InvestorPlace
    Earnings Scheduled For March 24, 2023
    Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely to report earnings for its fourth quarter. • Caledonia Mining (AMEX:CMCL) is projected to report earnings for its fourth... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
    Via Benzinga
    Over $16 Million Bet On Energy Transfer? Check Out These 3 Stocks Insiders Are Buying
    Although US stocks closed lower on Monday, there were a few notable insider trades. 
    Via Benzinga
    Analyst Ratings for POINT Biopharma Global
    Over the past 3 months, 5 analysts have published their opinion on POINT Biopharma Global (NASDAQ:PNT) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
    Via Benzinga
    Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
    Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
    Via Benzinga
    Dow Surges 150 Points; Crude Oil Falls Sharply
    U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday. 
    Via Benzinga
    Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
    Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target. 
    Via Benzinga
    Lantheus-POINT Biopharma Ink Strategic Collaboration For Cancer Programs
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Gainers 
    Via Benzinga
    Stocks Cool Off From Last Week's Rally
    Stocks are starting the week off lower, unable to build off of last week's impressive rally. 
    Via Talk Markets
    Silver Rises Over 1%; Tyson Foods Posts Downbeat Earnings
    U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping around 60 points on Monday. 
    Via Benzinga
    Hasbro, Ascendis Pharma, Coinbase Global And Some Other Big Stocks Moving Lower On Monday
    U.S. stocks traded mixed, with the Nasdaq gaining more than 50 points on Monday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    US Stocks Mostly Lower; Nasdaq Drops Over 100 Points
    U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday. 
    Via Benzinga
    Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
      
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
    Upgrades 
    Via Benzinga
    Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
    Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news. 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.